CancerGEMKB logo   CancerGEM KB (Cancer Genomic Evidence-based Medicine Knowledge Base) (version 1.0)
   An integrated, searchable knowledge base of cancer human genome epidemiology and genomic applications in cancer care and prevention .
line
 Last data upload: 17 Sep 2014. (Total 23458 articles)  

Cancer HuGE Literature Finder

Data collected since 2001

Home  |  About  |  Search Instructions |  FAQs 

Search  
 for
Search Criteria: All publications

Filtered By  

Articles 1 - 25 of 23458
Export Display on    of 939
1.
Cruciferous vegetables and risk of colorectal neoplasms: a systematic review and meta-analysis. [Detail]
Nutrition and cancer 2014 66 (1): 1.
Tse G, Eslick GD
2.
Variants in motilin, somatostatin and their receptor genes and risk of biliary tract cancers and stones in Shanghai, China. [Detail]
Meta gene 2014 Dec 2 .
Xu HL, Hsing AW, Koshiol J, Chu LW, Cheng JR, Gao J, Tan YT, Wang BS, Shen MC, Gao YT
3.
A polymorphism in the 3' untranslated region of Hypoxia-Inducible Factor-1 alpha confers an increased risk of cervical cancer in a?Chinese population. [Detail]
Neoplasma 2014 61 (1): 1.
Fu SL, Miao J, Ding B, Wang XL, Cheng WJ, Dai HH, Han SP
4.
ATM and TGFB1 genes polymorphisms in prediction of late complications of chemoradiotherapy in patients with locally advanced cervical cancer. [Detail]
Neoplasma 2014 61 (1): 1.
Paulikova S, Petera J, Sirak I, Vosmik M, Drastikova M, Dusek L, Cvanova M, Soumarova R, Spacek J, Beranek M
5.
Association between a functional polymorphism rs712 within let-7-binding site and risk of papillary thyroid cancer. [Detail]
Medical oncology (Northwood, London, England) 2014 Oct 31 (10): 10.
Jin H, Liang Y, Wang X, Zhu J, Sun R, Chen P, Nie X, Gao L, Zhang L
6.
Association between CCNE1 polymorphisms and the risk of breast cancer in a sample of southeast Iranian population. [Detail]
Medical oncology (Northwood, London, England) 2014 Oct 31 (10): 10.
Amininia S, Hashemi M, Ebrahimi M, Mashhadi MA, Hashemi SM, Taheri M, Ghavami S
7.
DNA repair gene XRCC1 Arg194Trp polymorphism and susceptibility to hepatocellular carcinoma: A meta-analysis. [Detail]
Oncology letters 2014 Oct 8 (4): 4.
Li W, Yang F, Gui Y, Bian J
8.
Frequency and features of TP53 mutation in 30 Chinese patients with sporadic basal cell carcinoma. [Detail]
Clinical and experimental dermatology 2014 Oct 39 (7): 7.
Wang YM, Huang YS, Ma ZH, Bu DF, Wang Y, Tu1 P, Li H
9.
Genetic polymorphisms in hypoxia-inducible factor-1a gene and its association with HBV-related hepatocellular carcinoma in a Chinese population. [Detail]
Medical oncology (Northwood, London, England) 2014 Oct 31 (10): 10.
Liu Y, Sui J, Zhai L, Yang S, Huang L, Huang L, Mo C, Wu J, Li S, Qin X
10.
Increased frequency of Mediterranean fever gene variants in multiple myeloma. [Detail]
Oncology letters 2014 Oct 8 (4): 4.
Celik S, Tangi F, Oktenli C
11.
KRAS mutational concordance between primary and metastatic colorectal adenocarcinoma. [Detail]
Oncology letters 2014 Oct 8 (4): 4.
Paliogiannis P, Cossu A, Tanda F, Palmieri G, Palomba G
12.
Sensitive methods for detection of the S768R substitution in exon 18 of the DDR2 gene in patients with central nervous system metastases of non-small cell lung cancer. [Detail]
Medical oncology (Northwood, London, England) 2014 Oct 31 (10): 10.
Nico? M, Powrózek T, Krawczyk P, Jarosz B, Paj?k B, Sawicki M, Kucharczyk K, Trojanowski T, Milanowski J
13.
The relationship of kinase insert domain receptor gene polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients treated with sorafenib. [Detail]
Medical oncology (Northwood, London, England) 2014 Oct 31 (10): 10.
Zheng YB, Zhan MX, Zhao W, Liu B, Huang JW, He X, Fu SR, Zhao Y, Li Y, Hu BS, Lu LG
14.
XELIRI compared with FOLFIRI as a second-line treatment in patients with metastatic colorectal cancer. [Detail]
Oncology letters 2014 Oct 8 (4): 4.
Cui C, Shu C, Yang Y, Liu J, Shi S, Shao Z, Wang N, Yang T, Hu S
15.
A functional variant at miR-34a binding site in toll-like receptor 4 gene alters susceptibility to hepatocellular carcinoma in a Chinese Han population. [Detail]
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Sep .
Jiang ZC, Tang XM, Zhao YR, Zheng L
16.
A let-7 microRNA-Binding Site Polymorphism in KRAS Predicts Improved Outcome in Patients with Metastatic Colorectal Cancer Treated with Salvage Cetuximab/Panitumumab Monotherapy. [Detail]
Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Sep 20 (17): 17.
Saridaki Z, Weidhaas JB, Lenz HJ, Laurent-Puig P, Jacobs B, De Schutter J, De Roock W, Salzman DW, Zhang W, Yang D, Pilati C, Bouché O, Piessevaux H, Tejpar S
17.
A multi-institutional study of the prevalence of BRCA1 and BRCA2 large genomic rearrangements in familial breast cancer patients. [Detail]
BMC cancer 2014 Sep 14 (1): 1.
Seong MW, Cho SI, Kim KH, Chung IY, Kang E, Lee JW, Park SK, Lee MH, Choi DH, Yom CK, Noh WC, Chang MC, Park SS, Kim SW
18.
A Newfound Association between MDC1 Functional Polymorphism and Lung Cancer Risk in Chinese. [Detail]
PloS one 2014 9 (9): 9.
Wang B, Zhang L, Qiu F, Fang W, Deng J, Zhou Y, Lu J, Yang L
19.
A polymorphism at miRNA-122-binding site in the IL-1? 3'UTR is associated with risk of epithelial ovarian cancer. [Detail]
Familial cancer 2014 Sep .
Zhang Z, Zhou B, Gao Q, Wu Y, Zhang K, Pu Y, Song Y, Zhang L, Xi M
20.
Analysis for loss of heterozygosity on chromosome arm 13q by STR analysis or SNP sequencing can replace analysis of FLT3-ITD to detect patients with prognostically adverse AML. [Detail]
Genes, chromosomes & cancer 2014 Sep .
Schnittger S, Haferlach C, Kern W, Haferlach T
21.
Androgen receptor polymorphisms and testicular cancer risk. [Detail]
Andrology 2014 Sep .
Grassetti D, Giannandrea F, Paoli D, Masciandaro P, Figura V, Carlini T, Rizzo F, Lombardo F, Lenzi A, Gandini L
22.
Assessment of DDR2, BRAF, EGFR and KRAS mutations as therapeutic targets in non-adenocarcinoma lung cancer patients. [Detail]
Molecular and clinical oncology 2014 Sep 2 (5): 5.
Yashima H, Shimizu K, Araki T, Aomori T, Ohtaki Y, Nagashima T, Enokida Y, Atsumi J, Nakamura T, Takeyoshi I, Yamamoto K
23.
Assessment of Glioma Risk Associated with an Inherited Variant at Chromosome 11q23. [Detail]
Cell biochemistry and biophysics 2014 Sep .
Li Z, Wang Y, Guo X, Zhang L, Dong C, Zhang J
24.
Association between a Variant in MicroRNA-646 and the Susceptibility to Hepatocellular Carcinoma in a Large-Scale Population. [Detail]
TheScientificWorldJournal 2014 2014 .
Wang R, Zhang J, Jiang W, Ma Y, Li W, Jin B, Hu H, Wang J, Liu Y, Liu J
25.
Association between chemokine receptor 5 delta32 polymorphism and susceptibility to cancer: a meta-analysis. [Detail]
Journal of receptor and signal transduction research 2014 Sep .
Lee YH, Song GG
Export Display 25 on page   1 of  939
Articles 1 - 25 of 23458